A Korean research team has developed a new viral vector technology that significantly improves the production efficiency of next-generation cell and gene therapies known as CAR immune cell therapies, ...
Hosted on MSN
Targeting viral envelope glycans offers promising path toward world's first broad-spectrum antiviral
Researchers at the Nanoscience Initiative at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have made a breakthrough in the fight against viral diseases. Subscribe to our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results